AptarGroup (NYSE:ATR) - Aandelenkoers, Nieuws & Analyse

ATR Overzicht aandelen

AptarGroup, Inc. ontwerpt en produceert een reeks oplossingen en diensten op het gebied van medicijnafgifte, afgifte van consumentenproducten en actieve materiaalwetenschap voor de farmaceutische, schoonheids-, persoonlijke verzorgings-, thuiszorg-, voedsel- en drankenmarkt. Meer informatie

ATR fundamentele analyse
Sneeuwvlok Score
Waardering	2/6
Toekomstige groei	1/6
Prestaties in het verleden	5/6
Financiële gezondheid	6/6
Dividenden	4/6

Beloningen

Verhandeld tegen 11.3% onder onze schatting van de reële waarde

De winst zal naar verwachting met 7.88% per jaar groeien

De winst groeide het afgelopen jaar met 19.5%

Risicoanalyse

Aanzienlijke insider-verkoop in de afgelopen 3 maanden

Community Narratives

Create a narrative

Narratives bring a range of perspectives from our community.

WarrenAI

Based on Analyst Price Targets

Aptar's Innovative Expansions And Calculated Alliances Ignite Future Growth Potential

Key Takeaways Strategic acquisitions and facility expansions are set to boost revenue by entering new therapeutic areas and increasing production capacity in key markets. Collaborations and innovative technologies are anticipated to enhance earnings and margins by improving efficiencies, competitiveness, and creating new revenue streams.

View narrative

US$188.00

9.6% undervalued

6.02%

Revenue growth p.a.

1 day ago

AptarGroup, Inc. Concurrenten

Crown Holdings

NYSE:CCK

US$10.7b

Ball

NYSE:BALL

US$18.0b

Berry Global Group

NYSE:BERY

US$7.9b

Silgan Holdings

NYSE:SLGN

US$5.8b

Prijsgeschiedenis en prestaties

Overzicht van alle hoogtepunten, veranderingen en prijsdalingen voor AptarGroup
Historische aandelenkoersen
Huidige aandelenkoers	US$169.88
52 Week Hoogtepunt	US$178.03
52 Week Laag	US$122.29
Bèta	0.57
11 maand verandering	2.45%
3 maanden verandering	12.92%
1 Jaar Verandering	32.13%
33 jaar verandering	32.53%
5 jaar verandering	50.56%
Verandering sinds IPO	3,384.72%

Recent nieuws en updates

Here's Why We Think AptarGroup (NYSE:ATR) Is Well Worth Watching

Nov 14

Are Investors Undervaluing AptarGroup, Inc. (NYSE:ATR) By 46%?

Oct 28

Recent updates

Here's Why We Think AptarGroup (NYSE:ATR) Is Well Worth Watching

Nov 14

Are Investors Undervaluing AptarGroup, Inc. (NYSE:ATR) By 46%?

Oct 28

Risks To Shareholder Returns Are Elevated At These Prices For AptarGroup, Inc. (NYSE:ATR)

Oct 14

Return Trends At AptarGroup (NYSE:ATR) Aren't Appealing

Sep 17

Is AptarGroup (NYSE:ATR) A Risky Investment?

Aug 16

AptarGroup, Inc. (NYSE:ATR) Just Released Its Second-Quarter Earnings: Here's What Analysts Think

Jul 31

AptarGroup: Shares Are Pumped Up

Jul 16

AptarGroup (NYSE:ATR) Has Announced That It Will Be Increasing Its Dividend To $0.45

Jul 15

Here's Why Shareholders May Want To Be Cautious With Increasing AptarGroup, Inc.'s (NYSE:ATR) CEO Pay Packet

Apr 25

AptarGroup (NYSE:ATR) Has A Pretty Healthy Balance Sheet

Mar 28

Here's Why We Think AptarGroup (NYSE:ATR) Is Well Worth Watching

Mar 07

Risks To Shareholder Returns Are Elevated At These Prices For AptarGroup, Inc. (NYSE:ATR)

Feb 21

AptarGroup, Inc. (NYSE:ATR) Shares Could Be 23% Below Their Intrinsic Value Estimate

Feb 08

AptarGroup (NYSE:ATR) Has More To Do To Multiply In Value Going Forward

Jan 26

AptarGroup: Exceptional Quality, But Priced For Perfection

Jan 18

We Think AptarGroup (NYSE:ATR) Can Stay On Top Of Its Debt

Dec 12

If EPS Growth Is Important To You, AptarGroup (NYSE:ATR) Presents An Opportunity

Nov 29

AptarGroup: The Market Price Has Run Ahead Of Its Performance

Oct 20

Slowing Rates Of Return At AptarGroup (NYSE:ATR) Leave Little Room For Excitement

Sep 22

AptarGroup, Inc. (NYSE:ATR) Shares Could Be 25% Below Their Intrinsic Value Estimate

Sep 07

AptarGroup (NYSE:ATR) Has A Pretty Healthy Balance Sheet

Aug 23

Do AptarGroup's (NYSE:ATR) Earnings Warrant Your Attention?

Aug 03

AptarGroup: There Are Better Prospects Out There

Jul 29

AptarGroup (NYSE:ATR) Will Pay A Larger Dividend Than Last Year At $0.41

Jul 17

A Look At The Fair Value Of AptarGroup, Inc. (NYSE:ATR)

Jun 09

AptarGroup (NYSE:ATR) Has More To Do To Multiply In Value Going Forward

May 25

AptarGroup (NYSE:ATR) Is Paying Out A Dividend Of $0.38

Apr 24

Is AptarGroup (NYSE:ATR) Using Too Much Debt?

Apr 03

AptarGroup Non-GAAP EPS of $0.92 beats by $0.13, revenue of $795.91M beats by $20.34M

Feb 16

Aptar Pharma launches nasal spray pump

Jan 30

AptarGroup: A Solid Business That's Just A Bit Too Pricey

Jan 17

AptarGroup realigns two business reporting segments

Dec 13

AptarGroup (NYSE:ATR) Seems To Use Debt Quite Sensibly

Dec 12

AptarGroup Non-GAAP EPS of $0.95 beats by $0.01, revenue of $836.86M misses by $1.63M

Oct 27

Rendement voor aandeelhouders

	ATR	US Packaging	US Markt
7D	-2.4%	3.2%	0.3%
1Y	32.1%	29.2%	31.1%

Rendement versus industrie: ATR overtrof de US Packaging industrie, die het afgelopen jaar een rendement 29.2 % opleverde.

Rendement versus markt: ATR overtrof de US markt, die het afgelopen jaar een rendement opleverde van 31.1 %.

Prijsvolatiliteit

Is ATR's price volatile compared to industry and market?
ATR volatility
ATR Average Weekly Movement	2.4%
Packaging Industry Average Movement	3.7%
Market Average Movement	6.2%
10% most volatile stocks in US Market	15.8%
10% least volatile stocks in US Market	3.1%

Stabiele aandelenkoers: ATR heeft de afgelopen 3 maanden geen significante prijsvolatiliteit gekend.

Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit ( 2% ) van ATR is het afgelopen jaar stabiel geweest.

Over het bedrijf

Opgericht	Werknemers	CEO	Website
1992	13,800	Stephan Tanda	www.aptar.com

AptarGroup, Inc. ontwerpt en produceert een reeks oplossingen en diensten op het gebied van medicijnafgifte, distributie van consumentenproducten en actieve materiaalwetenschap voor de farmaceutische, schoonheids-, persoonlijke verzorgings-, thuiszorg-, en voedsel- en drankenmarkten. Het bedrijf is actief via de segmenten Aptar Pharma, Aptar Beauty en Aptar Closures. Het bedrijf levert ook pompen voor neusallergiebehandelingen en kleppen voor dosisinhalatoren voor aandoeningen van de luchtwegen, zoals astma en chronische obstructieve longaandoeningen, elastomeer voor injecteerbare primaire verpakkingscomponenten en actieve materiaalwetenschappelijke oplossingen.

AptarGroup, Inc. Samenvatting

Hoe verhouden de winst en inkomsten van AptarGroup zich tot de beurswaarde?
ATR fundamentele statistieken
Marktkapitalisatie	US$11.23b
Inkomsten(TTM)	US$335.95m
Inkomsten(TTM)	US$3.57b

33.6x

Koers/Winstverhouding

3.2x

P/S-verhouding

Is ATR overgewaardeerd?

Zie Reële waarde en waarderingsanalyse

Inkomsten en omzet

Belangrijkste winstgevendheidsstatistieken uit het laatste winstverslag (TTM)
ATR resultatenrekening (TTM)
Inkomsten	US$3.57b
Kosten van inkomsten	US$2.23b
Brutowinst	US$1.34b
Overige uitgaven	US$1.00b
Inkomsten	US$335.95m

Laatst gerapporteerde inkomsten

Sep 30, 2024

Volgende inkomensdatum

n.v.t.

Winst per aandeel (EPS)	5.05
Brutomarge	37.45%
Nettowinstmarge	9.40%
Schuld/Eigen Vermogen Verhouding	42.0%

Hoe presteerde ATR op de lange termijn?

Bekijk historische prestaties en vergelijking

Dividenden

1.1%

Huidig dividendrendement

33%

Uitbetalingsratio

ATR Overzicht aandelen

Beloningen

Risicoanalyse

Aptar's Innovative Expansions And Calculated Alliances Ignite Future Growth Potential

AptarGroup, Inc. Concurrenten

NYSE:CCK

US$10.7b

NYSE:BALL

US$18.0b

NYSE:BERY

US$7.9b

NYSE:SLGN

US$5.8b

Prijsgeschiedenis en prestaties

Recent nieuws en updates

Here's Why We Think AptarGroup (NYSE:ATR) Is Well Worth Watching

President of Aptar Beauty recently sold US$673k worth of stock

President notifies of intention to sell stock

Are Investors Undervaluing AptarGroup, Inc. (NYSE:ATR) By 46%?

Third quarter 2024 earnings: EPS exceeds analyst expectations while revenues lag behind

AptarGroup, Inc. Provides Earnings Guidance for the Fourth Quarter of 2024

Recent updates

Here's Why We Think AptarGroup (NYSE:ATR) Is Well Worth Watching

President of Aptar Beauty recently sold US$673k worth of stock

President notifies of intention to sell stock

Are Investors Undervaluing AptarGroup, Inc. (NYSE:ATR) By 46%?

Third quarter 2024 earnings: EPS exceeds analyst expectations while revenues lag behind

AptarGroup, Inc. Provides Earnings Guidance for the Fourth Quarter of 2024

Price target increased by 8.2% to US$175

Risks To Shareholder Returns Are Elevated At These Prices For AptarGroup, Inc. (NYSE:ATR)

Second quarter dividend of US$0.45 announced

AptarGroup, Inc. (NYSE:ATR) announces an Equity Buyback for $500 million worth of its shares.

Return Trends At AptarGroup (NYSE:ATR) Aren't Appealing

Executive VP & CFO notifies of intention to sell stock

President of Aptar Asia recently sold US$1.1m worth of stock

Is AptarGroup (NYSE:ATR) A Risky Investment?

AptarGroup, Inc. Announces Unidose Liquid System Approves by the U.S. FDA for Allergic Reactions

President notifies of intention to sell stock

AptarGroup, Inc. (NYSE:ATR) Just Released Its Second-Quarter Earnings: Here's What Analysts Think

AptarGroup, Inc. Announces Chief Financial Officer Changes

AptarGroup: Shares Are Pumped Up

AptarGroup (NYSE:ATR) Has Announced That It Will Be Increasing Its Dividend To $0.45

First quarter dividend increased to US$0.45

AptarGroup, Inc. Declares Quarterly Cash Dividend , Payable on August 15, 2024

Here's Why We Think AptarGroup (NYSE:ATR) Is Well Worth Watching

Now 21% undervalued after recent price drop

Getting In Cheap On AptarGroup, Inc. (NYSE:ATR) Is Unlikely

Calculating The Intrinsic Value Of AptarGroup, Inc. (NYSE:ATR)

Price target increased by 7.1% to US$159

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

Here's Why Shareholders May Want To Be Cautious With Increasing AptarGroup, Inc.'s (NYSE:ATR) CEO Pay Packet

Fourth quarter dividend of US$0.41 announced

AptarGroup, Inc. Declares Quarterly Dividend, Payable on May 16, 2024

Now 20% undervalued

AptarGroup (NYSE:ATR) Has A Pretty Healthy Balance Sheet

Now 21% undervalued

President of Aptar Pharma recently sold US$500k worth of stock

Here's Why We Think AptarGroup (NYSE:ATR) Is Well Worth Watching

President notifies of intention to sell stock

Now 20% undervalued

Risks To Shareholder Returns Are Elevated At These Prices For AptarGroup, Inc. (NYSE:ATR)

Full year 2023 earnings: EPS misses analyst expectations

AptarGroup, Inc. (NYSE:ATR) Shares Could Be 23% Below Their Intrinsic Value Estimate

AptarGroup (NYSE:ATR) Has More To Do To Multiply In Value Going Forward

Upcoming dividend of US$0.41 per share at 1.3% yield

AptarGroup, Inc., Annual General Meeting, May 01, 2024

AptarGroup: Exceptional Quality, But Priced For Perfection

Now 21% undervalued after recent price drop

We Think AptarGroup (NYSE:ATR) Can Stay On Top Of Its Debt

If EPS Growth Is Important To You, AptarGroup (NYSE:ATR) Presents An Opportunity

Now 21% undervalued after recent price drop

Third quarter 2023 earnings: EPS and revenues miss analyst expectations

AptarGroup, Inc. Provides Earnings Guidance for the Fourth Quarter of 2023

AptarGroup: The Market Price Has Run Ahead Of Its Performance

Upcoming dividend of US$0.41 per share at 1.3% yield

AptarGroup, Inc. Declares Quarterly Cash Dividend, Payable on November 16, 2023

Slowing Rates Of Return At AptarGroup (NYSE:ATR) Leave Little Room For Excitement

AptarGroup, Inc. (NYSE:ATR) Shares Could Be 25% Below Their Intrinsic Value Estimate

AptarGroup, Inc. Appoints Sarah Glickman to Board of Directors

Independent Director notifies of intention to sell stock